London, United Kingdom

Stephen Mather

This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Queen Mary & Westfield College. Active years: 2017.

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Stephen Mather

Introduction

Stephen Mather is a notable inventor based in London, GB. He has made significant contributions to the field of medicine, particularly in the diagnosis and therapy of arthropathies. His innovative work has led to the development of a unique antibody composition that has potential therapeutic applications.

Latest Patents

Stephen Mather holds a patent for an invention titled "Antibody and use in diagnosis and therapy of arthropathies." This patent describes a composition comprising an antibody or fragment against oxidized Collagen II (CII), which is conjugated to a pharmaceutically active moiety. The invention also includes a composition with a detectable label, enhancing its utility in medical diagnostics and treatment.

Career Highlights

Mather is affiliated with Queen Mary & Westfield College, where he has been involved in research and development in the biomedical field. His work focuses on creating innovative solutions for complex medical challenges, particularly those related to joint diseases.

Collaborations

Stephen Mather has collaborated with notable colleagues, including Ahuva Nissim and Yuti Chernajovsky. These partnerships have fostered a collaborative environment that enhances the research and development of new medical therapies.

Conclusion

Stephen Mather's contributions to the field of medicine through his innovative patent demonstrate his commitment to advancing healthcare solutions. His work continues to impact the diagnosis and treatment of arthropathies, showcasing the importance of innovation in medical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…